A new Russian study shows that a combination of levofloxacin and rezonizate is effective in a murine model of Mycobacterium tuberculosis
Rezonizate is a new antituberculosis drug and its efficacy in combination with fluoroquinolones was tested in a murine model of TB.
Pathomorphological and microbiological testing showed that the greatest therapeutic effect was obtained when rezonizate was used in combination with levofloxacin while the weakest therapeutic effect was obtained when rezonizate was used in combination with gatifloxacin.
Antibiot Khimioter. 2011;56(7-8):22-6.
Source : http://www.ncbi.nlm.nih.gov/pubmed/22359865?dopt=Abstract